Investors

Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Shareholder Information

Date	Title	Document
08/12/20	Notice of 2020 AGM	Download
12/02/20	Shareholder Circular and Notice of General Meeting to be held on 2 March 20	Download
19/06/19	Notice of 2019 AGM	Download
05/02/19	Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver	Download
28/09/18	Shareholder Circular and Notice of General Meeting to be held on 15 October 18	Download
13/08/18	Notice of 2018 AGM	Download
28/09/17	Notice of General Meeting to be held on 16 October 2017	Download
11/04/17	Notice of Annual General Meeting 2017	Download
12/10/16	Notice of General Meeting to be held on 28 October 2016	Download
11/05/16	Notice of 2016 AGM	Download
21/05/15	Notice of 2015 AGM	Download

Share Detail


Number of shares	63,073,852
Country of listing	UK / US
Status	AIM Listed / NASDAQ Listed
Index	FTSE AIM All Share / NASDAQ
FTSE Sector	Pharmaceutical & Biotechnology
FTSE sub-sector	Biotechnology
Ticker	MTPH / MTP
CUSIP	GB00BKT14T00

The percentage of 0.1p Ordinary shares not being held in public hands is 17%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 10 December 2020.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name	Number of shares	%
CMS Medical Venture Investment (HK) Limited*	5,194,805	8.2
A&B (HK) Company Limited*	5,194,805	8.2
Lombard Odier Asset Management (Europe) Limited	4,885,556	7.7